Evercore ISI Group Maintains Outperform on Abbott Laboratories, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an Outperform rating on Abbott Laboratories (ABT) and raises the price target from $120 to $125.
April 04, 2024 | 4:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group analyst Vijay Kumar maintains an Outperform rating on Abbott Laboratories and raises the price target from $120 to $125.
The increase in price target by a reputable analyst firm like Evercore ISI Group suggests a strong confidence in Abbott Laboratories' future performance. This endorsement is likely to positively influence investor sentiment and potentially drive up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100